Table 2.

Causes of death





Patients randomized for consolidation

All patients
Patients not randomized for consolidation
MOPP/ABV ×8
ABVPP ×8
MOPP/ABV ×6 + RT
ABVPP ×6 + RT
Patients at risk, no.   533   115   92   116   114   96  
Total deaths, no.   129   56   21   11   18   23  
Deaths related to HL, no.       
    Failure to achieve CR   44   30   4   —   4   6  
    After relapse   16   2   2   4   2   6  
Deaths related to initial treatment, no.   15   9   3   —   —   3  
Deaths related to salvage therapy, no.   7   2   1   2   1   1  
Deaths related to second cancer, no.       
    Solid tumor   15   4   4   —   4   3  
    Non-Hodgkin lymphoma   4   —   1   1   2   —  
    Acute leukemia - MDS   5   3   1   1   —   —  
Deaths related to cardiovascular causes, no.   1   —   1   —   —   —  
Deaths due to other known cause, no.   10   1   2   1   3   3  
Cause of death unspecified, no.
 
12
 
5
 
2
 
2
 
2
 
1
 




Patients randomized for consolidation

All patients
Patients not randomized for consolidation
MOPP/ABV ×8
ABVPP ×8
MOPP/ABV ×6 + RT
ABVPP ×6 + RT
Patients at risk, no.   533   115   92   116   114   96  
Total deaths, no.   129   56   21   11   18   23  
Deaths related to HL, no.       
    Failure to achieve CR   44   30   4   —   4   6  
    After relapse   16   2   2   4   2   6  
Deaths related to initial treatment, no.   15   9   3   —   —   3  
Deaths related to salvage therapy, no.   7   2   1   2   1   1  
Deaths related to second cancer, no.       
    Solid tumor   15   4   4   —   4   3  
    Non-Hodgkin lymphoma   4   —   1   1   2   —  
    Acute leukemia - MDS   5   3   1   1   —   —  
Deaths related to cardiovascular causes, no.   1   —   1   —   —   —  
Deaths due to other known cause, no.   10   1   2   1   3   3  
Cause of death unspecified, no.
 
12
 
5
 
2
 
2
 
2
 
1
 

or Create an Account

Close Modal
Close Modal